StockDriftsStockDriftsTop 4 Ponoi Management, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics Inc | 52.54% | 1.60M | $38K | new | — | 2022-09-30 | |
| NGM | NGM Biopharmaceuticals Inc | 23.2% | 1.30M | $17K | new | — | 2022-09-30 | |
| RVMD | Revolution Medicines Inc | 18.44% | 685.0K | $14K | new | — | 2022-09-30 | |
| NRIX | Nurix Therapeutics Inc | 5.82% | 327.1K | $4K | new | — | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Ponoi Management, Llc reports $73.24K in US-listed equity holdings across 4 positions in its most recent 13F filing. Its largest disclosed positions are RAPT (52.5%), NGM (23.2%) and RVMD (18.4%). Figures reflect the Q3 2022 filing.
Sign up free to track Ponoi Management, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Ponoi Management, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1720702). View Ponoi Management, Llc’s 13F filings on SEC